Page last updated: 2024-08-23

4-methoxyamphetamine and Wallerian Degeneration

4-methoxyamphetamine has been researched along with Wallerian Degeneration in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Callaghan, PD; Daws, LC; Irvine, RJ; Javors, MA; Jones, DJ; Owens, WA; Sanchez, TA1

Other Studies

1 other study(ies) available for 4-methoxyamphetamine and Wallerian Degeneration

ArticleYear
In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
    Journal of neurochemistry, 2007, Volume: 100, Issue:3

    Topics: Amphetamines; Animals; Binding, Competitive; Hippocampus; Male; Metabolic Clearance Rate; N-Methyl-3,4-methylenedioxyamphetamine; Presynaptic Terminals; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Wallerian Degeneration

2007